Wordt geladen...
RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes
RES-529 (previously named Palomid 529, P529) is a phosphoinositide 3-kinase (PI3K)/AKT/mechanistic target of rapamycin (mTOR) pathway inhibitor that interferes with the pathway through both mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) dissociation. This compound is currently being developed i...
Bewaard in:
| Gepubliceerd in: | Anticancer Drugs |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Lippincott Williams & Wilkins
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4881730/ https://ncbi.nlm.nih.gov/pubmed/26918392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000354 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|